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a b s t r a c t
Background: Recently is has been shown that α- and β-hederin increase the β2-adrenergic responsive-
ness of alveolar type II cells (A549) and human airway smooth muscle cells (HASM), respectively, by
inhibiting the internalization of β2-adrenergic receptors (β2AR) under stimulating conditions. Internal-
ization of β2AR is initiated by phosphorylations of certain serines and threonines by cAMP dependent
protein kinase A (PKA) and G protein-coupled receptor kinases (GRK).
Purpose: To evaluate the effect of α-hederin on PKA and GRK2 mediated phosphorylation of GFP-tagged
β2AR.
Study design: To study this process we performed In-Cell Western using isoprenaline stimulated HEK293
cells overexpressing β2AR as GFP fusion protein and speciﬁc antibodies against PKA (Ser345/346) and
GRK2 (Ser355/356) phosphorylation sites.
Results: There was no effect found on the PKA mediated phosphorylation (n = 14) but we could show
that α-hederin (1 μM, 12 h) signiﬁcantly inhibits GRK2 mediated phosphorylation at Ser355/356 by
11 ± 5% (n ≥ 29, p ≤ 0.01) under stimulating conditions compared to the positive control. In Förster
resonance energy transfer (FRET) experiments using the isolated kinases in solution α-hederin did not
show any inﬂuence neither to GRK2 nor to PKA.
Conclusion: Taken together, these results indicate that α-hederin acts as an indirect GRK2 inhibitor lead-
ing to a reduced homologous desensitization of β2AR-GFP in HEK293 cells
© 2015 The Authors. Published by Elsevier GmbH.













Dry extracts from Hedera helix Linné, Araliaceae leaves are well
established in the treatment of acute and chronic diseases of the
respiratory tract associated with coughing. Their effects are de-
scribed as bronchospasmolytic and secretolytic and are proven by
spirometric and body plethysmographic investigations in random-
ized placebo-controlled clinical trials and post-marketing surveil-
lance studies (Gulyas et al, 1997; Hofmann et al., 2003; Kraft,
2004; Mansfeld et al., 1997, Mansfeld et al., 1998).
Saponins are considered to be pharmacologically active com-
pounds of H. helix leaves dry extracts by increasing the β2-
adrenergic responsiveness of alveolar type II cells and bronchial
muscle cells, respectively. Among them, α- and β-hederin whichAbbreviations: β2AR, β2-adrenergic receptor; PKA, protein kinase A; GRK2, G
protein-coupled receptor kinase 2; GFP, green ﬂuorescent protein; FRET, Förster res-
onance energy transfer.
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0944-7113/© 2015 The Authors. Published by Elsevier GmbH. This is an open access articlake up approx. 1% and 0.1%, respectively, depending on the ex-
raction procedure inhibit the internalization of β2-adrenergic re-
eptors (β2AR) under stimulating conditions followed by an in-
reased β2AR binding and an elevated cAMP production in vitro
Greunke et al., 2015; Sieben et al., 2009).
An elevated intracellular cAMP level causes the intensiﬁed pro-
uction and secretion of surfactant from alveolar type II cells
A549), liquefying viscous mucus associated with diseases of the
espiratory tract. In bronchial muscle cells the increased cAMP
evel leads to protein kinase A (PKA) mediated phosphorylation
f the myosin light-chain kinase (MLCK) which prevents the for-
ation of the MLCK-calmodulin/Ca2+ complex required for muscle
ontraction (Giembycz and Newton, 2006). Additionally, the intra-
ellular Ca2+-level decreases due to inﬂux inhibition through cal-
ium channels and inhibition of release from intracellular stores
Johnson, 1998). These effects provide the biochemical basis to
xplain the secretolytic and bronchospasmolytic properties of H.
elix leaves dry extracts seen within patients in clinical studies
Mansfeld et al., 1997; Mansfeld et al., 1998).e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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rTo date it is not clear in which manner α- and β-hederin
nhibit the internalization of β2AR. However, it is established
hat the internalization process is initiated by phosphorylation of
he β2AR. This desensitization is either mediated by phosphory-
ation of Ser345/346 and Ser261/262 by PKA (heterologous de-
ensitization) or by phosphorylation of certain serines, especially
er355/356 in the C-terminus of β2AR by G-protein coupled re-
eptor kinase 2 (GRK2) (homologous desensitization) (Tran et al.,
004). The desensitized β2AR is subsequently redistributed to a
oated pit and ﬁnally internalized in form of early endosomes by
ndocytosis (Ferguson, 2001).
H. helix leaves contain several monodesmosidic saponins in
hich α-hederin dominates quantitatively (Fig. 1).
In the present paper our approach was to investigate the inﬂu-
nce of α-hederin on the desensitization of β2AR overexpressed
s green ﬂuorescent protein (GFP) fusion protein in human embry-
nic kidney 293 (HEK293) cells by means of In-Cell Western. Bis-
esmosidic saponins like hederacoside C and corresponding agly-
ones like hederagenin were not further investigated because they
id not inﬂuence the internalization of β2AR (Sieben et al., 2009).
aterials and methods
hemicals
α-Hederin was obtained from HWI-Analytik (Rülzheim, Ger-
any, batch no. 301174836, m/z = 750,98 for C41H66O12). Purity
f α-hederin was investigated by HPLC (Waters, Eschborn, Ger-
any) equipped with a HPLC pump (MSDS 600 E), an autosam-
ler (WISP 700), a diode array detector (996) and a four-channel-
nline degasser (Knauer, Berlin). The MILLENNIUM V2.1 software
as used for data analysis and processing. The following parame-
ers were used: sample preparation: 5.20 mg α-hederin dissolved
n 25.00 ml methanol, column: LiChrospher® 100 RP18, 5 μm,
25 × 4 mm (Merck, Darmstadt, Germany), diode array detec-
or: 205 nm, injection volume: 20 μl, mobile phase A: dest. wa-
er/acetonitrile = 44/2 (v/v); adjust to pH 2 using phosphoric acid
85%), mobile phase B: acetonitrile, gradient: 0–9 min 100% A, 9-
0 min to 6% B, 10–25 min to 15% B, 25–50 min to 60% B, 50–
1 min to 100% B. Retention time of α-hederin was 48.8 min. Pu-
ity of α-hederin was 98.6%. All other reagents were obtained from
erck (Darmstadt, Germany), if not stated otherwise.
ell culture
HEK293 cells obtained from DSMZ (No. ACC 305) (Braun-
chweig, Germany) were cultivated in DMEM medium (Life Tech-
ologies, Carlsbad, CA) supplemented with 100 units/ml penicillin,00 μg/ml streptomycin, and 10% fetal calf serum. Cells were used
or experiments after reaching a conﬂuence of 70–80%.
ransfection of HEK293 cells
The β2AR-GFP construct was a kind donation of M. J. Lohse (De-
artment of Pharmacology and Toxicology, University of Würzburg,
ermany). The cloning procedure of the β2AR-GFP plasmid and the
ransfection of the HEK 293 cells were described previously (Kallal
t al., 1998; Sieben et al., 2009).
ive cell imaging
Pictures of live HEK293 cells stably expressing β2AR-GFP were
aken with an Axiovert® 200 M (Zeiss, Jena) ﬂuorescence micro-
cope equipped with argon laser, beam splitter HFT 488/543, oil
mmersion objective (Plan Apochromat 63x/1.4), bandpass ﬁlter BP
05-530, and pinhole 96 mm was used. Pictures were recorded
ith an AxioCam® (Zeiss, Jena, resolution of 512 × 512 pixels)
amera. The camera was controlled by the Axiovision® (Zeiss,
ena, release 4.7) software. For internalization experiments, cells
ere incubated for 30 min. with 10 μM terbutaline hemisulfate in
ocke’s solution (154.0 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl2 dihy-
rate, 1.0 mM MgCl2 hexahydrate, 3.6 mM NaHCO3, 5.0 mM HEPES,
nd 2.0 mM D-(+)-glucose monohydrate, pH 7.3). All pictures were
aken at 20 °C.
estern blot
For Western blots HEK293 cells stably expressing β2AR-GFP
ere starved overnight in serum-free cell culture medium. They
ere washed with ice cold PBS (137 mM NaCl, 10 mM Na2HPO4 ·
H2O, 2.7 mM KCl, 2 mM K2HPO4, pH 7.4) and resuspended
ith solubilization buffer (150 mM NaCl, 20 mM HEPES, 20 mM
a4P2O7, 10 mM NaF, 10 μg/ml leupeptin, 10 μg/ml phos-
hatase inhibitor cocktail 2, 10 μg/ml protease inhibitor cocktail
, 10 μg/ml trypsin inhibitor, 0.9% n-dodecyl-β-D-maltoside) for
0 min. in motion at 4 °C. Cell debris was centrifuged at 20,000 g
or 15 min. Partly, the lysate was used for the protein determi-
ation according to Bradford using the BioRad protein assay Kit
I (BioRad Laboratories, Herkules, CA). The remaining lysate was
iluted with native sample buffer (50 mM Tris-HCl pH 6.8, 40%
lycerol, 0.01% bromophenol blue), and applied equally to a Na-
ive PAGE gel containing 4% polyacrylamide in the stacking gel and
% polyacrylamide in the resolving gel, respectively. The proteins
ere stacked at 40 V and separated at 90 V in the resolving gel
nd subsequently incubated for ﬁve min. in 1% SDS solution before
t was blotted in the semi-dry method to PVDF membrane with
.5 mA/cm2 for 2 h. The membrane was washed with water and
locked overnight at 4 °C with Odyssey blocking Buffer (LI-COR
iosciences, Bad Homburg, Germany). Finally, the membrane was
ncubated with the primary antibodies in Odyssey blocking buffer
ontaining 0.1% Tween 20 for 1.5 h. To conﬁrm the stable trans-
ection of HEK293 cells a rabbit antibody against the C-terminus
f the β2-adrenergic receptor was used (Santa Cruz Biotechnol-
gy Inc., Santa Cruz, CA, sc-9042, diluted 1:1,000). Additionally
ntibodies against the phosphorylation sites Ser 345/346 for PKA
Santa Cruz Biotechnology Inc., sc-16718-R, diluted 1:500) and Ser
55/356 for GRK2 (Santa Cruz Biotechnology Inc., sc-16719-R, di-
uted 1:500) were used to prove the quality of the antibodies used
n the In-Cell Western. After ﬁve washing steps with 0.1% Tween-
0 in PBS, the membranes were incubated with a secondary goat
nti rabbit IRDye800 coupled antibody (LI-COR Biosciences, Bad
omburg, Germany, 926-32211, diluted 1:50,000) for 1 h. After ﬁve
ashing steps with PBS detection was done in the Odyssey plate
eader at 700 nm and at 800 nm.
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Fig. 2. (A) Internalization of β2AR-GFP after stimulation with 10 μM terbutaline for
30 min and (B) Western blots of β2AR-GFP (a) and isoprenaline-induced phospho-





























The In-Cell Western was performed in 96-well plates which
were coated overnight with PDL solution and seeded with 15,000
cells per well. The HEK293-β2AR-GFP cells were grown to a con-
ﬂuence of about 80% and starved overnight in serum-free cul-
ture medium. Simultaneously pre-incubation with α-hederin was
performed overnight. For negative controls cells were either incu-
bated for 20 min. with 1 μM GRK2-Inhibitor methyl-5-[2-(5-nitro-
2-furyl)vinyl]-2-furoate (Iino et al., 2002) (EMD Chemicals, NJ) or
for 1 h with 7.5 μM PKA inhibitor H89 (Lochner and Moolman,
2006). Stimulation was done with 0.25 μM or 0.5 μM isopre-
naline for 20 min., except for the unstimulated control cells. To
prevent dephosphorylation cells were ﬁxed with 4% PFA solution
and 15% sucrose. All following steps were performed at room tem-
perature and under slight movement. After permeating ﬁve times
with 0.1% Triton-X 100 in TBS the remaining unphosphorylated re-
ceptors were blocked with Odyssey® blocking buffer (LI-COR Bio-
sciences, Bad Homburg, Germany, P/N 927- 40000) for 1 h hour.
Incubation with the primary antibodies against the PKA (sc-16718-
R rabbit 1:200) and GRK2 phosphorylated receptor (sc-16719-R
rabbit 1:200) was performed for 2.5 h. After ﬁve washing steps
with 0.1% Tween-20 in PBS the secondary antibody, coupled to
IRDye800 (LI-COR Biosciences, Bad Homburg, Germany, IRDye-GAR
goat anti rabbit, P/N 926-32211, diluted 1:800), was added for 1 h
in the dark. An additive of Draq5 (DNA stain) and Sapphire700
(unspeciﬁc cell stain) was used for cell number normalization. Nu-
clear staining control was performed without Draq5 (Biostatus, Le-
icestershire, UK) and Sapphire700 (LI-COR Biosiences). After further
washing steps on the Odyssey® Imager (LI-COR Biosciences) detec-
tion took place using Odyssey® Application Software 3.0.21 at 700
and 800 nm. Data were analyzed with an In-Cell Western Plug-In
from LI-COR. The results are shown as the integrated intension at
800 nm, which correlates with the phosphorylation intensity, nor-
malized to the cell count measured at 700 nm and corrected for
the background, measured in cells without staining.
FRET
Förster resonance energy transfer (FRET) experiments were per-
formed in 384-well microplates (Greiner Bio One International
GmbH, Kremsmünster, Austria) using the Z´-LyteTM kinase assay Kit
Ser/Thr 1 (Life Technologies) for the PKA mediated phosphorylation
and the Z´-LyteTM kinase assay Kit Ser/Thr 16 (Life Technologies)
for the GRK2 mediated phosphorylation, respectively. ATP/substrate
mixture (1 nM substrate, 400 nM ATP, 6 nM cAMP) dissolved in
kinase buffer (250 mM HEPES (pH 7.5), 50 mM MgCl2, 5 mM
EGTA, 0.05% Brij-35) was placed to each well ﬁrst and subsequently
phosphorylated after addition of the corresponding kinase for 1 h.
Kinases dissolved in 0.5% DMSO were used in concentrations of
0.63 μM (50 ng/μl) for GRK2 and 1.15 μM (50 ng/μl) for PKA.
Development reagent diluted with development buffer was added
and the plate was further incubated for 1 h. The reaction was
terminated by adding stop solution (Proprietary reagent, Cat. Nr.
P3094). The reaction mixtures were measured on a Tecar® Genius
Reader (Tecan, Maennedorf, Switzerland) at 460 nm and 535 nm.
The results are shown as emission ratio of ﬂuorescence intension at
460 nm to 535 nm normalized to the solvent control (0.5% DMSO).
As positive control for both assays, the broad spectrum kinase in-
hibitor staurosporine dissolved in 0.5% DMSO was used in a con-
centration of 50 μM for GRK2 inhibition and 20 μM for PKA in-
hibition (Ruegg and Burgess, 1989). Emission ratio of ﬂuorescence
intension at 460 to 535 nm for unphosphorylated substrate was
determined in an approach without kinases. α-Hederin was tested
in a concentration of 1 μM.tatistical data evaluation
Statistical data evaluation was performed with one factorial
nalysis of variance (ANOVA) after their normal distribution was
nsured by means of a D´Agostino & Pearson normality test. Dun-
ett’s post hoc test was subsequently performed. Results were con-
idered to be signiﬁcant for p values of < 0.05.
esults
erbutaline-induced internalization and detection of
soprenaline-induced phosphorylation of β2AR-GFP
HEK293 cells overexpressing the β2AR-GFP were used to study
he phosphorylation of β2AR under stimulating conditions.
GFP-tagged β2AR function was proven by stimulation with
0 μM isoprenaline for 30 min. and a subsequent pronounced en-
ocytotic β2AR-GFP internalization, which was recognized by large
ntracellular vesicles (Fig. 2A and Video 1 Supplemental material).
The presence of β2AR-GFP and both GRK2 mediated β2AR
hosphorylation at Ser 355/356 and PKA-mediated β2AR phospho-
ylation at Ser 345/346 in isoprenaline stimulated HEK293-β2AR-
FP cells were demonstrated by Western blots (Fig. 2B). As ex-
ected, the receptor and its two phosphorylated forms showed a
imilar migration in the running gel which also demonstrated the
unctionality of the primary antibodies (Fig. 2B).
ffect of α-hederin on the PKA and GRK2 mediated phosphorylation
f β2AR-GFP in HEK293 cells
The inﬂuence of α-hederin on the phosphorylation of β2AR by
RK2 and PKA was investigated in concentrations between 0.1 μM
nd 1 μM using the In-Cell Western method. Stably transfected
EK293-β2AR-GFP cells were incubated for 20 min. with 0.25 μM
soprenaline as positive control which led to a statistically signiﬁ-
ant increase of PKA mediated phosphorylation at Ser 345/346 of
0.6 ± 6.4% (n ≥ 12, p ≤ 0.001) compared to untreated control
ells. Pre-treatment with 7.5 μM H89 (PKA inhibitor) for 60 min.
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Fig. 3. Effect of α-hederin on isoprenaline-induced ß2AR-GFP phosphorylation at Ser 345/346 (A) and Ser 355/356 (B) in HEK293-β2AR-GFP cells. Positive control was
0.5 μM isoprenaline (iso). As negative control served 7.5 μM H89 (PKA inhibitor) and 1 μM methyl-5-[2-(5-nitro-2-furyl)vinyl]-2-furoate (GRK2 inhibitor). pβ2AR-GFP was









































































thowed a statistically signiﬁcant decrease of the isoprenaline in-
uced phosphorylation of 18.2 ± 7.6% (n ≥ 14, p < 0.05) com-
ared to the positive control, whereas pre-treatment with 1 μM
-hederin for 12 h showed no inﬂuence (n = 14) (Fig. 3A).
Cells stimulated with 0.5 μM isoprenaline for 20 min. (posi-
ive control) revealed a statistically signiﬁcant increase of GRK2-
ediated Ser 355/356 phosphorylation of β2AR of 30.0 ± 4.1% (n ≥
9, p < 0.001) compared to untreated control cells. Pre-incubation
ith 1 μM of methyl-5-[2-(5-nitro-2-furyl)vinyl]-2-furoate (GRK2
nhibitor) statistically signiﬁcant decreased the isoprenaline in-
uced phosphorylation by 19.7 ± 5.3% (n = 29, p < 0.001) com-
ared to the positive control (Fig. 3B). Pre-treatment with α-
ederin in a concentration range between 0.1 μM and 1 μM
ed to a dose-dependent inhibition of the isoprenaline induced
nd GRK2-mediated β2AR-GFP phosphorylation. Under stimulating
onditions 1 μM α-hederin inhibited the Ser 355/356 phosphory-
ation statistically signiﬁcant with 11.1 ± 5% (n ≥ 29, p < 0.01)
ompared to the positive control (Fig. 3B).
ffect of α-hederin on the PKA and GRK2 activity in solution
The direct inﬂuence of α-hederin on the GRK2 activity in so-
ution was studied with the Z´-LyteTM kinase assay Kit 16. The
easurement is based on a FRET signal of a coumarin and ﬂuo-
escein double-labeled protein (substrate) under proteolytic condi-
ions. GRK2 dissolved in 0.5% DMSO (solvent control) in a concen-
ration of 0.63 μM prevents the proteolytic cleavage by phospho-
ylation of the substrate and the corresponding FRET signal calcu-
ated as emission ratio at 440 nm and 535 nm (Em440/535) nor-
alized to the value 1.0 ± 0.08 (n = 19). Compared to the pure
RK2 approach DMSO showed no change in the GRK2 activity (n
18) (Fig. 4A). The applied substrate revealed a relative increase
f the Em440/535 value by a factor of 1.71 ± 0.23 (n = 19) after
aximum proteolytic cleavage. Fifty μM of the broad spectrum ki-
ase inhibitor staurosporine served as positive control. Compared
o GRK2 dissolved in 0.5% DMSO the Em440/535 value statistically
igniﬁcant increased by 47.3 ± 5.4% (n = 19, p < 0.001). One μM
f α-hederin for 60 min. did not show any inﬂuence on the GRK2
ctivity. The corresponding Em440/535 value was 1.05 ± 0.1 (n = 12)
nd comparable to the solvent control (Fig. 4A).
The direct inﬂuence of α-hederin on the PKA activity was deter-
ined with the Z´-LyteTM kinase assay Kit Ser/Thr 1. The coumarin
nd ﬂuorescein double-labeled protein (substrate) showed a sta-istically signiﬁcant increase of the Em440/535 value by a factor of
.31 ± 0.12 (p < 0.001, n = 6) after maximum proteolytic cleav-
ge, compared to the approach with 1.15 μM PKA dissolved in 0.5%
MSO.
Compared to the pure PKA approach its activity was not in-
uenced by DMSO (PKA control) (n = 5). Twenty μM of the
road spectrum inhibitor staurosporine was used as positive con-
rol which led to a statistically signiﬁcant increase of the Em440/535
alue by 76.7 ± 21.2% (n = 6, p < 0.001) compared to the activ-
ty of PKA dissolved in 0.5% DMSO. An inhibitory effect of 1 μM
-hederin to PKA activity was not observed (n = 5) (Fig. 4B).
iscussion
H. helix leaves dry extracts are used in the treatment of acute
nd chronic respiratory tract diseases associated with coughing
Gulyas et al, 1997; Hofmann et al., 2003; Kraft, 2004; Mansfeld
t al., 1997, Mansfeld et al., 1998). Based on clinical studies and
vailable scientiﬁc data they are classiﬁed by the European Com-
ittee on Herbal Medicinal Products (HMPC) for a “well estab-
ished use” in the treatment of cough associated with viscous mu-
us and hypersecretion.
Although the mode of action of H. helix leaves dry extracts is
ot yet fully understood it has been shown to contain saponins
.g. α- and β-hederin that enhance the β2AR responsiveness in
549 and HASM cells, respectively, which mediates the secre-
olytic and bronchospasmolytic effect (Greunke et al., 2015; Sieben
t al., 2009). Recently Wolf et al. (2011) were able to show that
re-treatment with α-hederin improves isoprenaline-mediated re-
axation of methacholine pre-contracted muscle strips of bovine
rachea.
The responsiveness of many G protein-coupled receptors (GPCR)
nd thus also for the β2AR is regulated at conditions of high ag-
nist concentrations by heterologous and homologous desensitiza-
ion and subsequently by internalization.
In heterologous desensitization the β2AR is phosphorylated by
he cAMP dependent PKA in the third intracellular loop or in the
-terminal region on Ser261/262 and Ser345/346 (Nobles et al.,
011). Phosphorylation leads to an uncoupling of the associated G
rotein and a switch of G protein association from Gs to Gi is also
iscussed (Benovic, 2002). The switch to Gi would additionally an-
agonize the ligand induced receptor activation.
56 J. Schulte-Michels et al. / Phytomedicine 23 (2016) 52–57
Fig. 4. Effect of α-hederin on GRK2- (A) and PKA-mediated (B) substrate phosphorylation investigated by FRET in solution. Substrate was a coumarin and ﬂuorescein double-






































iIn homologous desensitization the β2AR is phosphorylated at
several serines and threonines in the C-terminus by GRKs. GRKs
are serine/threonine kinases with seven subtypes discovered so far
(GRK1-7) (Penela et al., 2003). β2ARs in HEK293 cells are mainly
associated to the subtypes 2 and 6 (GRK2/6) (Nobles et al., 2011).
GRK2 is located in the cytosol and needs free Gβy dimers to as-
sociate with the membrane, thus in contrast to PKA it only phos-
phorylates activated receptors (Kohout and Lefkowitz, 2003). Phos-
phorylation by GRK2 induces uncoupling of G protein Gsα and fur-
ther promotes the binding of arresting proteins called arrestins
(Kallal et al., 1998). So far four family members of β-arrestins (β-
arr) have been found, of which β-arr2 is predominant for β2ARs
(Marchese et al., 2003). β-arr2 binds to the GRK phosphorylated
receptor and interacts with a clathrin adaptor protein (AP-2). The
complex now enables clathrin to associate with the receptor and
to build a clathrin coated pit in which the receptor is internalized
via endocytosis (Claing et al., 2002; Marchese et al., 2003). Depen-
dent to ongoing stimulation of the cell β2ARs can be relocated to
the plasma membrane or degraded. It has been shown by Krasel
et al. (2008) that the phosphorylation of several serines by GRKs in
the cluster between Ser355 and Ser364 is essential for β-arrestin
binding and thus for β2AR internalization (Krasel et al., 2008).
Compared to α-hederin the structurally related β-hederin is
present only in very small amounts in the H. helix leaves dry ex-
tract, and therefore plays a minor role for the pharmacological ef-
fects (Greunke et al., 2015). For this reason, only α-hederin was in-
vestigated in the present study. The α-hederin mediated increase
of β2-adrenergic responsiveness in A549 and HASM cells can be
explained by inhibition of β2AR internalization and thereby an in-
creased β2AR binding and formation of cAMP. Our ﬁndings on the
inﬂuence of α- hederin on the PKA and GRK2 mediated phospho-
rylation of β2AR, respectively, lead to the conclusion that the inhi-
bition of homologue desensitization is causal for the repression of
β2AR internalization.
Since the ability to investigate phosphorylation level by In-Cell
Western has been proven before by other research groups (Du
et al., 2007), we performed own In-Cell Western experiments and
were able to show a dose-dependent inhibition of the GRK2 me-
diated phosphorylation at Ser355/356 by α-hederin under stimu-
lating conditions. As a positive control 0.5 μM isoprenaline was
used, which resulted in increased phosphorylation of GFP-ß AR2f about 30.0 ± 4.1%. On the other hand Shi et al. (2011) found
n increased phosphorylation of hemagglutinin (HA) tagged β2AR
f about 60% in HEK293 cells for a comparable concentration of
albutamol. While for Shi et al. (2011) the extracellular N-terminus
f β2AR was tagged with HA, in our experiments the intracellu-
ar C-terminus was tagged with GFP. Possibly the intracellular GFP-
ag affects the interaction with GRK2, which could explain the ob-
erved lower isoprenaline mediated phosphorylation of GFP-β2AR.
oreover, salbutamol is a stronger agonist compared to isopre-
aline, which also may lead to higher phosphorylation rates. One
M α-hederin led to a decrease of 11.1 ± 5% in β2AR phospho-
ylation while lower concentrations (0.1 μM and 0.5 μM) did not
how signiﬁcant inhibition of GRK2 mediated phosphorylation. Re-
arkably, Shi et al. (2011) found a 30% inhibition of salbutamol
ediated phosphorylation of HA-ß2AR in HEK293 cells, however,
sing a signiﬁcantly higher concentration of 100 μM glycyrrhetic
cid (GA), a structural related saponin from liqourice.
An inﬂuence of α-hederin on the PKA mediated phosphoryla-
ion of GFP-β2AR could not been determined.
We further performed FRET experiments in solution but did not
nd any direct effect of α-hederin on the phosphorylation potency
f the two kinases. Thus it appears that the effect of α-hederin
n GRK2 is mediated indirectly in cell experiments. Saponins are
embrane-active substances that interact with membrane compo-
ents such as phospholipids and cholesterol, and thereby modulate
embrane dynamics and possibly functions of membrane associ-
ted proteins (Augustin et al., 2011; Lorent et al., 2014). Membrane
ntegrated α-hederin could interfere in this way the interaction be-
ween β2AR and GRK2.
Our results agree with earlier ﬁndings of Shi et al. (2011) who
howed that GA also enhances the β2AR responsiveness by GRK2
nhibition. They showed that GA reduces the plasma membrane
holesterol and thus changes the ﬂuidity of plasma membranes
eading to a release of raft-associated Gαs which increases the
2AR-Gαs coupling and subsequently decreases β2AR internaliza-
ion (Shi et al., 2012). Although the used concentration of GA
100 μM) is considerably higher than we applied for α-hederin (1
M), the ﬁndings on the β2AR phosphorylation seem to indicate
similar mode of action. Due to the lower dose used, one could
ssume that α-hederin seems to be even more potent in the GRK2
nhibition.


















































WFurther studies regarding the recruitment of β-arr2 and GRK2
o β2AR could give information about how α-hederin inhibits the
omologue desensitization.
onclusion
In clinical studies secretolytic and bronchospasmolytic effects
ere described for Hedera helix leaves dry extracts. So far, these
ffects have been explained by a α-hederin mediated inhibi-
ion of β2AR internalization and subsequently an increase in β2-
drenergic responsiveness of the airways. Until now, the molecular
echanism responsible for the inhibition of β2AR internalization
as not been described. The present paper indicates α-hederin as
n indirect GRK2 inhibitor. By demonstrating a reduced homolo-
ous desensitization the α-hederin mediated internalization inhibi-
ion of β2AR under stimulating conditions can be explained. Thus,
nother important aspect in the mode of action of α-hederin as a
harmacological relevant ingredient of H. helix leaves dry extract
ould be clariﬁed.
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